{
      "date": "2026-05-12",
      "uri": "https://arxiv.universalpublishings.com/id/eprint/54746",
      "id_number": "oai:ojs2.journal.urdti.uz:article/583",
      "type": "article",
      "full_text_status": "none",
      "official_url": "http://journal.urdti.uz/index/article/view/583",
      "subjects": [
        "sut bezi saratoni",
        "immunoonkologiya",
        "biomarkerlar",
        "HER2",
        "PD-L1"
      ],
      "userid": 1,
      "note": "Imported from URDTI Journal (OAI id oai:ojs2.journal.urdti.uz:article/583)",
      "ispublished": "pub",
      "metadata_visibility": "show",
      "date_type": "published",
      "rev_number": 1,
      "datestamp": "2026-05-26 15:47:16",
      "publisher": "South Aral Region Medical Journal",
      "lastmod": "2026-05-26 15:47:16",
      "publication": "South Aral Region Medical Journal",
      "eprint_status": "archive",
      "keywords": "sut bezi saratoni; immunoonkologiya; biomarkerlar; HER2; PD-L1",
      "sword_depositor": 1,
      "dir": "disk0/00/05/47/46",
      "creators": [
        {
          "name": {
            "family": "Urmanbayeva",
            "lineage": null,
            "honourific": null,
            "given": "Dilbarhon"
          }
        },
        {
          "name": {
            "given": "Gulnozakhon",
            "honourific": null,
            "family": "Abdivokhobova",
            "lineage": null
          }
        },
        {
          "name": {
            "honourific": null,
            "given": "Uktamxon",
            "lineage": null,
            "family": "Adhamjonova"
          }
        },
        {
          "name": {
            "given": "Shoxista",
            "honourific": null,
            "family": "Erkinova",
            "lineage": null
          }
        }
      ],
      "eprintid": 54746,
      "title": "SUT BEZI SARATONINI ERTA TASHXISLASH VA DAVOLASHDA IMMUNOONKOLOGIK TEKSHIRUVLARNING AHAMIYATI",
      "status_changed": "2026-05-26 15:47:16",
      "abstract": "Mazkur maqolada sut bezi saratonini erta aniqlash va davolash samaradorligini oshirishda immunoonkologik tekshiruvlar, xususan interleykinlar (IL-6 va IL-10) ning diagnostik ahamiyati kompleks tahlil qilinadi. Tadqiqotning asosiy maqsadi \u2014 an\u2019anaviy biomarkerlar (HER2, PD-L1, gormonal retseptorlar) bilan bir qatorda interleykinlarni qo\u2018llash orqali kasallikni erta aniqlash, prognoz qilish va individual davolash strategiyasini takomillashtirishdan iborat. Tadqiqot jarayonida IL-6 va IL-10 ning biologik roli, o\u2018sma jarayonlari bilan bog\u2018liqligi hamda klinik-diagnostik ahamiyati baholandi. Natijalar shuni ko\u2018rsatdiki, IL-6 darajasining oshishi o\u2018sma proliferatsiyasi va agressivligi bilan bog\u2018liq bo\u2018lsa, IL-10 immunosupressiv muhitni shakllantirib, kasallik prognoziga ta\u2019sir ko\u2018rsatadi. Interleykinlarni aniqlash diagnostik aniqlikni oshirib, kasallikni erta bosqichda aniqlash imkonini beradi."
    }